Literature DB >> 7078399

Fever in the pediatric and young adult patient with cancer. A prospective study of 1001 episodes.

P A Pizzo, K J Robichaud, R Wesley, J R Commers.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1982        PMID： 7078399     DOI： 10.1097/00005792-198205000-00003

Source DB:  PubMed          Journal:  Medicine (Baltimore)        ISSN： 0025-7974            Impact factor:   1.889


× No keyword cloud information.
  31 in total

1.  Prevalence and Predictors of Invasive Fungal Infections in Children with Persistent Febrile Neutropenia Treated for Acute Leukemia - A Prospective Study.

Authors:  Jogender Kumar; Amitabh Singh; Rachna Seth; Immaculata Xess; Manisha Jana; Sushil Kumar Kabra
Journal:  Indian J Pediatr       Date:  2018-06-29       Impact factor: 1.967

2.  Evolution of the clinical manifestations of infection during the course of febrile neutropenia in patients with malignancy.

Authors:  E C Dompeling; J P Donnelly; J M Raemaekers; S C Deresinski; R Feld; B E De Pauw
Journal:  Infection       Date:  1998 Nov-Dec       Impact factor: 3.553

Review 3.  Management of acute febrile illness.

Authors:  D M Jaffe; S Torrey
Journal:  Indian J Pediatr       Date:  1988 Sep-Oct       Impact factor: 1.967

4.  Empiric antifungal therapy and outcomes in extremely low birth weight infants with invasive candidiasis.

Authors:  Rachel G Greenberg; Daniel K Benjamin; Marie G Gantz; C Michael Cotten; Barbara J Stoll; Michele C Walsh; Pablo J Sánchez; Seetha Shankaran; Abhik Das; Rosemary D Higgins; Nancy A Miller; Kathy J Auten; Thomas J Walsh; Abbot R Laptook; Waldemar A Carlo; Kathleen A Kennedy; Neil N Finer; Shahnaz Duara; Kurt Schibler; Richard A Ehrenkranz; Krisa P Van Meurs; Ivan D Frantz; Dale L Phelps; Brenda B Poindexter; Edward F Bell; T Michael O'Shea; Kristi L Watterberg; Ronald N Goldberg; P Brian Smith
Journal:  J Pediatr       Date:  2012-03-15       Impact factor: 4.406

5.  Infections in acute leukemia: an analysis of 240 febrile episodes.

Authors:  R Jagarlamudi; L Kumar; V Kochupillai; A Kapil; U Banerjee; S Thulkar
Journal:  Med Oncol       Date:  2000-05       Impact factor: 3.064

6.  Imipenem or cefoperazone-sulbactam combined with vancomycin for therapy of presumed or proven infection in neutropenic cancer patients.

Authors:  G Bodey; D Abi-Said; K Rolston; I Raad; E Whimbey
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1996-08       Impact factor: 3.267

Review 7.  Supportive therapy in management of leukemias.

Authors:  V P Choudhry; N Desai
Journal:  Indian J Pediatr       Date:  1993 Mar-Apr       Impact factor: 1.967

8.  Ceftazidime versus ceftazidime plus tobramycin in febrile neutropenic children.

Authors:  R F Jacobs; T S Vats; K A Pappa; S Chaudhary; M Kletzel; D L Becton
Journal:  Infection       Date:  1993 Jul-Aug       Impact factor: 3.553

Review 9.  Febrile neutropenia.

Authors:  J Klastersky
Journal:  Support Care Cancer       Date:  1993-09       Impact factor: 3.603

10.  Changing causes of septicaemia in paediatric oncology patients: effect of imipenem use.

Authors:  J W Gray; S J Pedler; A W Craft; J Kernahan; K P Windebank; A D Pearson
Journal:  Eur J Pediatr       Date:  1994-02       Impact factor: 3.183
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.